A blood test that detects tumor DNA circulating in the bloodstream may help select the most effective treatment options for ...

For decades, most cancers were discovered only after symptoms appeared or through organ-specific screening tests like ...

When Amy Seitz got pregnant with her second child last year, she knew that being 35 years old meant there was an increased chance of chromosomal disorders like Down syndrome. She wanted to be screened ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...

cf-bDNA testing can reduce CRC incidence and mortality but is less effective and more costly than colonoscopy and FIT. The test may increase screening participation among those who avoid traditional ...

In a recent study published in The New England Journal of Medicine, a team of scientists from the United States (U.S.) and Canada evaluated the performance of a blood-based testing method that uses ...

New blood-based screening tests for colorectal cancer (CRC) offered fewer benefits at higher cost versus other screening options, a cost-effectiveness modeling study suggested. In a comparison against ...

The hope for many cancer patients who go through surgery is that they’ll be cured after the surgeon removes the tumor. The question that lingers is whether they got it all out — if the surgery ...

LAS VEGAS, Nev. (FOX5) - The VA Medical Center in North Las Vegas says they are the first hospital in the region to offer a new kind of testing. The goal is to look at a veteran patient’s DNA profile ...